Expression Table for this CRE
| CNhs12698 | K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 2.7 |
| CNhs11990 | Smooth Muscle Cells - Subclavian Artery, donor2 | 2.2 |
| CNhs11984 | Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2 | 0.8 |
| CNhs13332 | Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 0.7 |
| CNhs13333 | Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3) | 0.5 |
| CNhs13637 | Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 0.5 |
| CNhs11844 | acantholytic squamous carcinoma cell line:HCC1806 | 0.4 |
| CNhs14060 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 0.4 |
| SRX4001446 | CAGE profiling after treatment with JQ1 BET inhibitor in lung cancer cell line: H23_No_Treatment_R2 | 0.4 |
| CNhs12312 | hippocampus, adult, donor10252 | 0.4 |
| CNhs13541 | CD14+CD16+ Monocytes, donor1 | 0.3 |
| CNhs13851 | Myoblast differentiation to myotubes, day04, control donor1 | 0.3 |
| CNhs13603 | mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 0.3 |
| SRX4001457 | CAGE profiling after treatment with JQ1 BET inhibitor in lung cancer cell line: H23_JQ1_24h_R1 | 0.3 |
| CNhs14443 | COBL-a rinderpest(-C) infection, 24hr, biol_rep3 | 0.3 |
| CNhs13344 | Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 0.3 |
| CNhs14465 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3 | 0.3 |
| CNhs13598 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 0.3 |
| SRX4001447 | CAGE profiling after treatment with JQ1 BET inhibitor in lung cancer cell line: H23_No_Treatment_R3 | 0.2 |
| CNhs13397 | Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2) | 0.2 |
| CNhs13107 | Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9) | 0.2 |
| CNhs12405 | Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 0.2 |
| CNhs14587 | Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 0.2 |
| SRX4504723 | human CAGE MCF-7, response to HRG, 30 min, biol_rep3 | 0.2 |
| SRX4001449 | CAGE profiling after treatment with JQ1 BET inhibitor in lung cancer cell line: H23_JQ1_3h_R2 | 0.2 |
| CNhs13615 | mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1 | 0.2 |
| SRX4504706 | human CAGE MCF-7, response to HRG, 0 min, biol_rep1 | 0.2 |
| CNhs12922 | Mesenchymal Stem Cells - adipose, donor3 | 0.2 |
| SRX4001454 | CAGE profiling after treatment with JQ1 BET inhibitor in lung cancer cell line: H23_JQ1_12h_R1 | 0.2 |
| CNhs14590 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1 | 0.1 |
| CNhs12926 | Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1) | 0.1 |
| CNhs13110 | Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 0.1 |
| SRX4001456 | CAGE profiling after treatment with JQ1 BET inhibitor in lung cancer cell line: H23_JQ1_12h_R3 | 0.1 |
| SRX6586253 | CNhi10329_THP-1_Rosuvastatin-30 uM-48h_rep3 | 0.1 |
| SRX4504720 | human CAGE MCF-7, response to HRG, 360 min, biol_rep2 | 0.1 |
| CNhs11760 | aorta, adult, pool1 | 0.1 |
| CNhs11860 | fibrosarcoma cell line:HT-1080 | 0.1 |
| CNhs12443 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1 | 0.1 |
| CNhs13109 | Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11) | 0.1 |
| SRX6586230 | CNhi10326_THP-1_Simvastatin-30 uM-6h_rep2 | 0.1 |
| SRX6586217 | CNhi10322_HepG2_Simvastatin-30 uM-6h_rep1 | 0.0 |
| SRX6586219 | CNhi10322_HepG2_Simvastatin-30 uM-6h_rep3 | 0.0 |
| SRX6586204 | CNhi10321_HepG2_Atrovastatin-30 uM-6h_rep1 | 0.0 |
| ERX10345068 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345069 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345070 | human post-mortem brain tissue of the frontal lobe_patients with FTD-MAPT | 0 |
| ERX10345071 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345072 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345073 | human post-mortem brain tissue of the frontal lobe_patients with FTD-MAPT | 0 |
| ERX10345074 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |